Lancet iron study
This article was originally published in The Tan Sheet
"Current guidelines for universal supplementation with iron and folic acid should be revised" because "routine supplementation with iron and folic acid in preschool children in a population with high rates of malaria can result in an increased risk of severe illness and death," according to a study published in The Lancet Jan. 14. Sunil Sazawaal, Johns Hopkins University, et al., conducted an 18-month randomized, double-masked, placebo-controlled trial in Pemba, Zanzibar on children aged one month to 4 years. "Midway through the trial, the iron and folic acid-containing groups had to be stopped because they were associated with higher rates of adverse events (hospital admissions and deaths) than the zinc and placebo groups," the authors state. International guidelines currently recommend supplementation in children younger than two-years-old who live in areas with a high prevalence of anemia, Sazawaal et al. note...
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.